Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News IPI Legacy Liquidation Co IMPLQ

Healthcare Biotechnology
IPI Legacy Liquidation Co, formerly Impel Pharmaceuticals Inc., is not engaged in any business operations. The Company doesn’t hold any assets.

Recent & Breaking News (PINL:IMPLQ)

Impel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of "Stalking Horse" Agreement to Facilitate Sale

PR Newswire December 19, 2023

Impel Pharmaceuticals Announces Exploration of Strategic Alternatives

GlobeNewswire October 5, 2023

Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society

GlobeNewswire June 15, 2023

Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire May 12, 2023

Impel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer

GlobeNewswire May 10, 2023

Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023

GlobeNewswire May 5, 2023

Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine Medications

GlobeNewswire April 26, 2023

Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors

GlobeNewswire April 12, 2023

Impel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual Meeting

GlobeNewswire April 11, 2023

Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

GlobeNewswire March 24, 2023

Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023

GlobeNewswire March 17, 2023

Impel Pharmaceuticals to Participate in Upcoming Investor Conferences in March

GlobeNewswire March 3, 2023

Impel Pharmaceuticals Announces Strategic Repriortization, Continues Focus on Maximizing Trudhesa® Commercial Opportunity

GlobeNewswire February 22, 2023

Impel Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Corporate Update

GlobeNewswire November 14, 2022

Impel Pharmaceuticals to Participate in Guggenheim 4th Annual Immunology and Neurology Day

GlobeNewswire November 8, 2022

Impel Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

GlobeNewswire November 7, 2022

Impel Pharmaceuticals to Participate in Upcoming Investor Conferences in September

GlobeNewswire September 6, 2022

Impel Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update

GlobeNewswire August 15, 2022

Impel Pharmaceuticals to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022

GlobeNewswire August 8, 2022

Impel Pharmaceuticals to Participate in 2022 Wedbush PacGrow Healthcare Conference

GlobeNewswire August 2, 2022